Beslagsmed Jesper Rasmussen ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  4.9% 1.4% 1.6% 1.9% 1.8%  
Credit score (0-100)  46 79 73 70 70  
Credit rating  BBB A A A A  
Credit limit (kDKK)  0.0 21.9 4.1 0.8 1.6  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  1,256 0 0 0 1,146  
Gross profit  1,103 1,251 1,140 0.0 1,146  
EBITDA  455 656 529 503 542  
EBIT  445 610 483 453 491  
Pre-tax profit (PTP)  443.2 604.0 476.4 436.9 489.9  
Net earnings  351.1 486.4 393.3 353.4 388.5  
Pre-tax profit without non-rec. items  443 604 476 437 490  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  138 451 519 468 418  
Shareholders equity total  723 1,210 1,381 1,540 1,810  
Interest-bearing liabilities  0.0 0.0 94.2 62.2 36.2  
Balance sheet total (assets)  1,020 1,733 1,845 2,015 2,244  

Net Debt  -814 -1,168 -1,107 -1,336 -1,701  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  1,256 0 0 0 1,146  
Net sales growth  -8.5% -100.0% 0.0% 0.0% 0.0%  
Gross profit  1,103 1,251 1,140 0.0 1,146  
Gross profit growth  -11.1% 13.4% -8.8% -100.0% 0.0%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,020 1,733 1,845 2,015 2,244  
Balance sheet change%  55.9% 69.9% 6.5% 9.2% 11.3%  
Added value  455.2 655.6 528.6 497.7 542.0  
Added value %  36.2% 0.0% 0.0% 0.0% 47.3%  
Investments  81 266 23 -101 -101  

Net sales trend  -1.0 -2.0 0.0 0.0 0.0  
EBIT trend  2.0 3.0 4.0 5.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  36.2% 0.0% 0.0% 0.0% 47.3%  
EBIT %  35.4% 0.0% 0.0% 0.0% 42.9%  
EBIT to gross profit (%)  40.3% 48.7% 42.4% 0.0% 42.9%  
Net Earnings %  28.0% 0.0% 0.0% 0.0% 33.9%  
Profit before depreciation and extraordinary items %  28.8% 0.0% 0.0% 0.0% 38.3%  
Pre tax profit less extraordinaries %  35.3% 0.0% 0.0% 0.0% 42.8%  
ROA %  53.2% 44.3% 27.0% 23.4% 23.1%  
ROI %  81.2% 63.1% 36.0% 29.4% 28.5%  
ROE %  64.1% 50.3% 30.4% 24.2% 23.2%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  70.9% 69.8% 74.8% 76.4% 80.7%  
Relative indebtedness %  23.6% 0.0% 0.0% 0.0% 37.8%  
Relative net indebtedness %  -41.2% 0.0% 0.0% 0.0% -113.8%  
Net int. bear. debt to EBITDA, %  -178.9% -178.1% -209.4% -265.6% -313.8%  
Gearing %  0.0% 0.0% 6.8% 4.0% 2.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 14.9% 19.9% 3.2%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  2.9 2.4 2.8 3.2 4.2  
Current Ratio  3.0 2.5 2.9 3.3 4.2  
Cash and cash equivalent  814.4 1,167.8 1,201.2 1,398.2 1,737.0  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  17.0 0.0 0.0 0.0 25.6  
Trade creditors turnover (days)  175.1 0.0 0.0 0.0 0.0  
Current assets / Net sales %  70.2% 0.0% 0.0% 0.0% 159.4%  
Net working capital  585.1 759.2 861.7 1,071.3 1,392.5  
Net working capital %  46.6% 0.0% 0.0% 0.0% 121.6%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0